Thermo Fisher Scientific Q3 GAAP operating income climbs 17% to $2.26 billion

Bitget2026/10/21 10:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Thermo Fisher Scientific’s third-quarter 2026 GAAP diluted earnings per share rose 9% year over year to $4.64.
Revenue climbed 9% to $12.14 billion, while GAAP operating income increased 17% to $2.26 billion.
The company completed its microbiology business divestiture and launched Precure with Mayo Clinic to advance earlier disease detection.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261020833836) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Thermo Fisher Scientific Q3 GAAP operating income climbs 17% to $2.26 billion

You may also like

Crypto prices